Sign in
4

Changes in Ownership

BioAge Labs, Inc. Filed Acc 0001210905-25-000004

Chief Medical Officer sold 68,897 shares at $10.19 ($701,909)

  • Chief Medical Officer acquired 68,897 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

RUBIN PAUL D · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-04 Exercise or conversion : show line 1 in the form 10b5-1 +68,897 $4.11 $283,167 68,897 D
2025-12-04 Sale : show line 2 in the form 10b5-1 −68,897 $10.19 $701,909 0 D
Open-market sales · 68,897 sh · avg $10.19 · $701,909

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-04 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −68,897 21,736 D
Loading xslF345X05/form4-12052025_111241.xml…